Globalization of the Indian Pharmaceutical Industry: Implications for Innovation
In this article we create an industry-wide metrics of innovation based on the characterization of learning potential of foreign direct invest-ment (FDI), technology acquisition and in-house R&D, analysis of patenting activity, assessment of R&D directions and evaluation of innovation outcomes. Our purpose is to reflect on strategies adopted for learning, competence building and innovation and for creating complementarities and linkages within India’s pharmaceutical industry during the post- Trade Related Intellectual Property Rights (TRIPs) period. With India facing the challenge of constituting pathways and strategies for accelerated learning, we also explore through whose actions, types of strategies and routes of growth have the limits of Indian pharmaceutical industry innovation been reached within one decade. Finally, how and with what kind of policy design can the Indian state and society intervene to push the frontier of innovation further within this industry. Indian state and business have chosen globalization pathways with specific implications for innovation. We assess systemic connections of these implications, suggesting that for a significant change in domestic and foreign pharmaceutical firms’ orientation to disease, as reflected in outcomes of their R&D investment activity, there also has to be a major focus on pathways toward innovation for domestic markets.
Volume (Year): 3 (2011)
Issue (Month): 2 (July)
|Contact details of provider:|| Postal: |
Web page: http://ijie.um.edu.my
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Athreye, Suma & Kale, Dinar & Ramani, Shyama V., 2008.
"Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector,"
MERIT Working Papers
041, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press, vol. 18(4), pages 729-759, August.
When requesting a correction, please mention this item's handle: RePEc:umk:journl:v:3:y:2011:i:2:p:327-365. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Professor Dr. Rajah Rasiah)
If references are entirely missing, you can add them using this form.